A systematic review of the efficacy of proton pump inhibitors on refractory adult asthma.

P. Li (CHENGDU, China)

Source: International Congress 2017 – Clinical points to ponder in asthma
Session: Clinical points to ponder in asthma
Session type: Thematic Poster
Number: 638
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Li (CHENGDU, China). A systematic review of the efficacy of proton pump inhibitors on refractory adult asthma.. 638

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis
Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020
Year: 2021



The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019

The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisyA systematic review and meta-analysis
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017

The use of pharmacological therapies in hospitalized COVID-19 patients– A literature review
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Prevalence of nonadherence to controller therapy in adults with severe asthma – a systematic review and meta-analysis
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Erdosteine is effective as a treatment for acute exacerbation of COPD: a systematic review of clinical trials
Source: International Congress 2017 – COPD management
Year: 2017


As needed therapies in mild to severe asthma: a systematic review and network meta-analysis
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
Source: Eur Respir J, 52 (6) 1801586; 10.1183/13993003.01586-2018
Year: 2018



Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018
Year: 2018



Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study
Source: Eur Respir J, 53 (5) 1802161; 10.1183/13993003.02161-2018
Year: 2019



Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019


Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD
Source: Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018
Year: 2018



Association between cyclooxygenase inhibitor use and efficacy of immunotherapy: a retrospective study
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Roles of PI3k pan-inhibitors and PI3k-d inhibitors in allergic lung inflammation: systematic review and a meta-analysis
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020


The efficacy of convalescent plasma therapy in severe COVID-19 patients: a systematic review
Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science
Year: 2021


Impact of therapy reviews in real-world asthma
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011